AR-V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration-resistant prostate cancer patients

Takatsugu Okegawa; Naoki Ninomiya; Kazuki Masuda; Yu Nakamura; Mitsuhiro Tambo; Kikuo Nutahara

doi:10.1002/pros.23501

AR-V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration-resistant prostate cancer patients

The Prostate ◽

10.1002/pros.23501 ◽

2018 ◽

Vol 78 (8) ◽

pp. 576-582 ◽

Cited By ~ 21

Author(s):

Takatsugu Okegawa ◽

Naoki Ninomiya ◽

Kazuki Masuda ◽

Yu Nakamura ◽

Mitsuhiro Tambo ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

TMPRSS2-ERG Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated With Abiraterone Acetate

European Urology ◽

10.1016/j.eururo.2011.07.011 ◽

2011 ◽

Vol 60 (5) ◽

pp. 897-904 ◽

Cited By ~ 147

Author(s):

Daniel C. Danila ◽

Aseem Anand ◽

Clifford C. Sung ◽

Glenn Heller ◽

Margaret A. Leversha ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Synaptophysin expression on circulating tumor cells in patients with castration resistant prostate cancer undergoing treatment with abiraterone acetate or enzalutamide

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2017.12.006 ◽

2018 ◽

Vol 36 (4) ◽

pp. 162.e1-162.e6 ◽

Cited By ~ 8

Author(s):

Sumanta K. Pal ◽

Miaoling He ◽

Lin Chen ◽

Lixin Yang ◽

Raju Pillai ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving 177Lu-PSMA-617 Radioligand Therapy

Theranostics ◽

10.7150/thno.44556 ◽

2020 ◽

Vol 10 (17) ◽

pp. 7645-7655

Author(s):

Katharina Kessel ◽

Robert Seifert ◽

Matthias Weckesser ◽

Wolfgang Roll ◽

Verena Humberg ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Molecular Analysis ◽

Castration Resistant Prostate Cancer ◽

Radioligand Therapy ◽

Castration Resistant

Download Full-text

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-018-0043-z ◽

2018 ◽

Vol 21 (3) ◽

pp. 411-418 ◽

Cited By ~ 12

Author(s):

Manish Kohli ◽

Jian Li ◽

Meijun Du ◽

David W Hillman ◽

Scott M. Dehm ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Plasma Cell ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Free Dna ◽

Prognostic Association

Download Full-text

Abstract 375: Phenotypic and molecular characterization of circulating tumor cells (CTCs) in patients with castration resistant prostate cancer (CRPC) undergoing treatment with abiraterone acetate or enzalutamide

10.1158/1538-7445.am2015-375 ◽

2015 ◽

Author(s):

Jaymala Patel ◽

Vipul Bhargava ◽

Miaoling He ◽

Brad Foulk ◽

Denis A. Smirnov ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Molecular Characterization ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e23025 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e23025-e23025

Author(s):

Darren W. Davis ◽

Asifa Haider ◽

Valerie Pierron ◽

Fabien Schmidlin

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

PD32-12 LONG-TERM FOLLOW-UP OF CIRCULATING TUMOR CELLS AS PREDICTORS FOR SURVIVAL IN MEN TREATED WITH ABIRATERONE ACETATE FOR CASTRATION RESISTANT PROSTATE CANCER FOLLOWING CHEMOTHERAPY

The Journal of Urology ◽

10.1016/j.juro.2016.02.688 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Christian Meyer ◽

Petra Strölin ◽

Hans Heinzer ◽

Klaus Pantel ◽

Sabine Riethdorf ◽

...

Keyword(s):

Prostate Cancer ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Long Term Follow Up

Download Full-text

Abstract 3196: Analysis of taxane drug target engagement of microtubules in circulating tumor cells from metastatic castration resistant prostate cancer patients treated with CRLX301, a nanoparticle of docetaxel

10.1158/1538-7445.am2020-3196 ◽

2020 ◽

Author(s):

Eiman Mukhtar ◽

Daniel Worroll ◽

Giuseppe Galletti ◽

Shelly Schuster ◽

Sarina A. Piha-Paul ◽

...

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Drug Target ◽

Target Engagement ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Abstract C9: Treatment response to abiraterone acetate (AA) in patients with castration-resistant prostate cancer (CRPC) based on circulating tumor cells (CTCs), prostate-specific antigen (PSA), and imaging

Cancer Research ◽

10.1158/1538-7445.prca2012-c9 ◽

2012 ◽

Vol 72 (4 Supplement) ◽

pp. C9-C9

Author(s):

Diletta Bianchini ◽

Alison Reid ◽

Gerhardt Attard ◽

Johann De Bono ◽

Shahneen Sandhu ◽

...

Keyword(s):

Prostate Cancer ◽

Treatment Response ◽

Prostate Specific Antigen ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Specific Antigen ◽

Abiraterone Acetate ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Initial presentation of prostate cancer may hint different clinical characteristics along with serving predictive biomarker in castration-resistant prostate cancer patients treated with abiraterone acetate

Leukemia Research ◽

10.1016/s0145-2126(19)30281-4 ◽

2019 ◽

Vol 85 ◽

pp. S34-S35

Author(s):

F. Kose ◽

A. Sedef ◽

A. Besen ◽

H. Mertsoylu

Keyword(s):

Prostate Cancer ◽

Cancer Patients ◽

Clinical Characteristics ◽

Predictive Biomarker ◽

Abiraterone Acetate ◽

Initial Presentation ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text